Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01594710
  4. Details
NCT01594710 Clinical Trial

Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults

Metabolic Syndrome, Atherosclerosis Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01594710
Other study ID # KoreaHealth_MS
Secondary ID
Status Completed
Phase N/A
First received April 28, 2012
Last updated October 12, 2015
Start date February 2012
Est. completion date May 2015

Study information
Verified date April 2014
Source Korea University
Contact n/a
Is FDA regulated No
Health authority South Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

In Asia, the prevalence of metabolic syndrome have been dramatically increased. Therefore, the investigators intend to the collect the blood sample, laboratory, anthropometric, and body composition parameters prospectively to examine the risk factors of metabolic syndrome. Furthermore, the investigators will collect the data of carotid IMT and branchial ankle pulse wave velocity to clarify the metabolic risk factors of atherosclerosis.

Recruitment information / eligibility
Status Completed
Enrollment 1800
Est. completion date May 2015
Est. primary completion date February 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- Apparently healthy people who underwent medical routine check up in Korea Health Promotion Center.

- age > 20 years

Exclusion Criteria:

- History of cardiovascular disease (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)

- Stage 2 hypertension

- Severe renal or hepatic disease

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Korea, Republic of Korea University Guro Hospital Seoul

Sponsors (1)
Lead Sponsor Collaborator
Korea University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary The impact of various cardiovascular risk factors (inflammatory markers, hepatokines, adipokines, body composition parameters) for developing metabolic syndrome in prospective design 36months No
Secondary The relationship of various cardiovascular risk factors (inflammatory markers, hepatokines, adipokines, body composition parameters) with metabolic syndrome and atherosclerosis measured by baPWV and carotid IMT in cross sectional design 36months No